Source

Commission Implementing Regulation (EU) 2026/1421 of 30 June 2026 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances bensulfuron, benzovindiflupyr, chlorotoluron, clethodim, cycloxydim, cymoxanil, dazomet, deltamethrin, diclofop, fenazaquin, fluopicolide, hymexazol, lambda-cyhalothrin, MCPA, MCPB, metaldehyde, metsulfuron-methyl, paclobutrazol and tebuconazole

Implementing Regulation (EU) 2026/1421 · Regulation · 3 articles

Data as of 2026-07-23 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

The Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.

Article 2

Open ↗

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

Supplementary provisions

ANNEXSupplementary provisions

Open ↗

ANNEX The Annex to Implementing Regulation (EU) No 540/2011 is amended as follows: 1. Part A is amended as follows: (1) in the sixth column, expiration of approval, of row 40, Deltamethrin, the date is replaced by ‘30 June 2028’; (2) in the sixth column, expiration of approval, of row 102, Chlorotoluron, the date is replaced by ‘30 June 2028’; (3) in the sixth column, expiration of approval, of row 107, MCPA, the date is replaced by ‘31 July 2028’; (4) in the sixth column, expiration of approval, of row 108, MCPB, the date is replaced by ‘31 July 2028’; (5) in the sixth column, expiration of approval, of row 263, Cymoxanil, the date is replaced by ‘30 November 2027’; (6) in the sixth column, expiration of approval, of row 268, Tebuconazole, the date is replaced by ‘31 July 2028’; (7) in the sixth column, expiration of approval, of row 271, Bensulfuron, the date is replaced by ‘15 November 2027’; (8) in the sixth column, expiration of approval, of row 297, Fluopicolide, the date is replaced by ‘31 January 2029’; (9) in the sixth column, expiration of approval, of row 316, Cycloxydim, the date is replaced by ‘31 January 2029’; (10) in the sixth column, expiration of approval, of row 322, Hymexazol, the date is replaced by ‘31 January 2029’; (11) in the sixth column, expiration of approval, of row 329, Clethodim, the date is replaced by ‘15 December 2027’; (12) in the sixth column, expiration of approval, of row 339, Dazomet, the date is replaced by ‘30 November 2029’; (13) in the sixth column, expiration of approval, of row 340, Metaldehyde, the date is replaced by ‘15 October 2028’; (14) in the sixth column, expiration of approval, of row 342, Fenazaquin, the date is replaced by ‘15 August 2028’; (15) in the sixth column, expiration of approval, of row 344, Diclofop, the date is replaced by ‘31 January 2029’; (16) in the sixth column, expiration of approval, of row 348, Paclobutrazol, the date is replaced by ‘31 January 2029’. 2. Part E is amended as follows: (1) in the sixth column, expiration of approval, of row 3, Metsulfuron-methyl, the date is replaced by ‘31 July 2029’; (2) in the sixth column, expiration of approval, of row 4, Benzovindiflupyr, the date is replaced by ‘2 January 2029’; (3) in the sixth column, expiration of approval, of row 5, Lambda-Cyhalothrin, the date is replaced by ‘31 January 2029’.

Other acts of the same type

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

What to look at next

Browse all EU Legal ActsEvery instrument by type and year, full text free to read section by sectionEuropean Union legislation EU Legal Acts by type and yearGrouped by instrument type and year of enactment, so you can find others of the same kindBrowse by type and year European Union: what this database coversWhich datasets are here, which official source they come from, and how current they areEuropean Union overview